217 related articles for article (PubMed ID: 10695710)
1. The immunopathogenesis of Miller Fisher syndrome.
Willison HJ; O'Hanlon GM
J Neuroimmunol; 1999 Dec; 100(1-2):3-12. PubMed ID: 10695710
[TBL] [Abstract][Full Text] [Related]
2. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
Yuki N
J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
Yuki N
Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes.
Kanzaki M; Kaida K; Ueda M; Morita D; Hirakawa M; Motoyoshi K; Kamakura K; Kusunoki S
J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1148-52. PubMed ID: 18339728
[TBL] [Abstract][Full Text] [Related]
5. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.
Koga M; Gilbert M; Li J; Koike S; Takahashi M; Furukawa K; Hirata K; Yuki N
Neurology; 2005 May; 64(9):1605-11. PubMed ID: 15883324
[TBL] [Abstract][Full Text] [Related]
6. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome.
Yuki N
Cell Mol Life Sci; 2000 Apr; 57(4):527-33. PubMed ID: 11130452
[TBL] [Abstract][Full Text] [Related]
7. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
Yuki N
Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome.
Ilyas AA; Cook SD; Mithen FA; Taki T; Kasama T; Handa S; Hamasaki H; Singhal BS; Li SC; Li YT
J Neuroimmunol; 1998 Mar; 82(2):160-7. PubMed ID: 9585812
[TBL] [Abstract][Full Text] [Related]
9. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome.
Jacobs BC; Endtz HP; van der Meché FG; Hazenberg MP; de Klerk MA; van Doorn PA
J Neuroimmunol; 1997 Oct; 79(1):62-8. PubMed ID: 9357448
[TBL] [Abstract][Full Text] [Related]
10. Clinical and immunological spectrum of the Miller Fisher syndrome.
Lo YL
Muscle Nerve; 2007 Nov; 36(5):615-27. PubMed ID: 17657801
[TBL] [Abstract][Full Text] [Related]
11. Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes.
Yuki N
Lancet Infect Dis; 2001 Aug; 1(1):29-37. PubMed ID: 11871407
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
Prendergast MM; Moran AP
J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.
Goodyear CS; O'Hanlon GM; Plomp JJ; Wagner ER; Morrison I; Veitch J; Cochrane L; Bullens RW; Molenaar PC; Conner J; Willison HJ
J Clin Invest; 1999 Sep; 104(6):697-708. PubMed ID: 10491405
[TBL] [Abstract][Full Text] [Related]
14. Anti-GQ1b-negative Miller Fisher syndrome after Campylobacter jejuni enteritis.
Lee KY
Pediatr Neurol; 2012 Sep; 47(3):213-5. PubMed ID: 22883289
[TBL] [Abstract][Full Text] [Related]
15. Anti-ganglioside complex antibody profiles in a recurrent complicated case of GQ1b-seronegative miller fisher syndrome and Bickerstaff brainstem encephalitis: a case report.
Ito H; Hatanaka Y; Fukami Y; Harada Y; Kobayashi R; Okada H; Uchibori A; Chiba A; Okuda S
BMC Neurol; 2018 May; 18(1):72. PubMed ID: 29792178
[TBL] [Abstract][Full Text] [Related]
16. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies.
Chiba A; Kusunoki S; Obata H; Machinami R; Kanazawa I
Neurology; 1993 Oct; 43(10):1911-7. PubMed ID: 8413947
[TBL] [Abstract][Full Text] [Related]
17. Anti-GQ1b antibody syndrome presenting as acute isolated bilateral ophthalmoplegia: Report on two patients and review of the literature.
Guisset F; Ferreiro C; Voets S; Sellier J; Debaugnies F; Corazza F; Deconinck N; Prigogine C
Eur J Paediatr Neurol; 2016 May; 20(3):439-43. PubMed ID: 26924168
[TBL] [Abstract][Full Text] [Related]
18. Anti-GQ1b IgG antibody syndrome: clinical and immunological range.
Odaka M; Yuki N; Hirata K
J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):50-5. PubMed ID: 11118247
[TBL] [Abstract][Full Text] [Related]
19. Anti-ganglioside antibodies and the presynaptic motor nerve terminal.
Willison HJ; Plomp JJ
Ann N Y Acad Sci; 2008; 1132():114-23. PubMed ID: 18567860
[TBL] [Abstract][Full Text] [Related]
20. Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection.
Schwerer B; Neisser A; Bernheimer H
Infect Immun; 1999 May; 67(5):2414-20. PubMed ID: 10225903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
